- Home
- CBAT vs ORMP Comparison
CBAT vs ORMP Comparison
Compare CBAT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- ORMP
- Stock Information
- Founded
- CBAT 1999
- ORMP 2002
- Country
- CBAT China
- ORMP United States
- Employees
- CBAT N/A
- ORMP N/A
- Industry
- CBAT Industrial Machinery/Components
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- ORMP Health Care
- Exchange
- CBAT Nasdaq
- ORMP Nasdaq
- Market Cap
- CBAT 90.4M
- ORMP 93.9M
- IPO Year
- CBAT N/A
- ORMP N/A
- Fundamental
- Price
- CBAT $0.88
- ORMP $2.28
- Analyst Decision
- CBAT
- ORMP
- Analyst Count
- CBAT 0
- ORMP 0
- Target Price
- CBAT N/A
- ORMP N/A
- AVG Volume (30 Days)
- CBAT 194.2K
- ORMP 91.7K
- Earning Date
- CBAT 11-11-2025
- ORMP 11-06-2025
- Dividend Yield
- CBAT N/A
- ORMP N/A
- EPS Growth
- CBAT N/A
- ORMP N/A
- EPS
- CBAT N/A
- ORMP N/A
- Revenue
- CBAT $145,462,366.00
- ORMP $2,000,000.00
- Revenue This Year
- CBAT N/A
- ORMP N/A
- Revenue Next Year
- CBAT $78.62
- ORMP N/A
- P/E Ratio
- CBAT N/A
- ORMP N/A
- Revenue Growth
- CBAT N/A
- ORMP N/A
- 52 Week Low
- CBAT $0.57
- ORMP $1.82
- 52 Week High
- CBAT $1.30
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- CBAT 40.32
- ORMP 54.51
- Support Level
- CBAT $0.88
- ORMP $2.24
- Resistance Level
- CBAT $0.92
- ORMP $2.45
- Average True Range (ATR)
- CBAT 0.04
- ORMP 0.06
- MACD
- CBAT -0.00
- ORMP 0.00
- Stochastic Oscillator
- CBAT 43.22
- ORMP 45.31
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.